UltraTech Cement Q2 profit rises 21% to ₹1,494 crore; sales up 19% on year
Ultratech Cement moved higher in a quarterly results development for Q2FY27.
· BS Companies, Economic Times Markets, ET Stocks
Net sales rose 18.9 per cent to ₹23,024 crore and domestic grey-cement volumes grew 13.8%, while PBIDT increased 17.3% to ₹3,832 crore on year in…
Key facts
- Period
- Q2FY27
The analysis
Ultratech Cement reported ₹1,494 crore, ₹23,024 crore and ₹3,832 crore for Q2FY27, with movement of 21%, 19% and 18.9% attached to those lines. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is -1.2% on the day at ₹11,045.00, and has returned -6.8% over three months. It sits 15% below its 52-week high. The cement & construction sector has moved -15.2% over the same period, so Ultratech Cement is running 8.4 points ahead of its peers.
For Ultratech Cement, the question is how much of this is already reflected in the price and how much re-rates the cement & construction peer set alongside it.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
Market context
- In focus: Ultratech Cement (ULTRACEMCO), in Cement & Construction.
- Over three months: Ultratech Cement -6.8% against Cement & Construction -15.2% (8.4 points ahead).
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| Ultratech CementULTRACEMCO · Cement & Construction | ₹11,045.00 | -1.2% | +0.8% | -6.8% | -15.4% | 0.8× | — |
Cement & Construction
1M -5.4% · 3M -15.2%
Ultratech Cement
Prices as of 30 Oct 2026, 16:11 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Ambuja Cements Q2 net profit plunges 90 pc as margins come under pressure
Ambuja Cements Q2 Results: Net profit tanks 90% YoY to Rs 114 crore on tax reversal effect; revenue rises 10%
Q2 Results Live: Varun Beverages Q3 Net Profit Rises 14% YoY; Reliance Slips, Sun Pharma Gains Ahead Of Earnings
Why is VBL down 5% despite Q3 PAT jumps on double-digit volume growth?
Airtel Africa Q2 profit rises 16% to $254 million, revenue up 26%